Multiplexed Molecular Profiling of Lung Cancer Using Pleural Effusion

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

Hippo Pathway Gene Mutations in Malignant Mesothelioma: Revealed by RNA and Targeted Exon Sequencing Akihiko Miyanaga, MD, PhD, Mari Masuda, PhD, Koji.
Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
The Accuracy of Frozen Section Diagnosis of Pulmonary Nodules: Evaluation of Inflation Method during Intraoperative Pathology Consultation with Cryosection.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?  Adrian G.
Two Classic Lyrics Joined by a Contemporary Tune—Environmental Pro-Carcinogen Exposure and Genetic Susceptibility in Lung Cancer Risk  Ping Yang, MD,
Surgical Intervention for Non–Small-Cell Lung Cancer Patients with Pleural Carcinomatosis: Results From the Japanese Lung Cancer Registry in 2004  Tomohiko.
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
ALK FISH and IHC: You Cannot Have One without the Other
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD 
The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer  Ramón Rami-Porta, MD, FETCS,
NA  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers
The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer  Hirotsugu Kenmotsu, MD, Tateaki Naito, MD, Madoka.
Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients  Hes A.P. Brokx, MD, Otto Visser, MD, PhD,
Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma  Kazuhisa Nakashima, MD, Tateaki Naito, MD, Shota Omori, MD, Shusuke Yoshikawa,
Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer  Daniel Morgensztern, MD, Saiama.
The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer  Peter Goldstraw, MB, FRCS, John J. Crowley, PhD 
Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non– Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI  Akito Hata,
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Pulmonary Metastasectomy: A Survey of Current Practice Amongst Members of the European Society of Thoracic Surgeons  Eveline Internullo, MD, Stephen D.
Boundary between N1 and N2 Lymph Node Descriptors in the Subcarinal Zone in Lower Lobe Lung Cancer: A Brief Report  Mitsuhiro Isaka, MD, Haruhiko Kondo,
Elderly Patients with Advanced NSCLC in Phase III Clinical Trials: Are the Elderly Excluded from Practice-Changing Trials in Advanced NSCLC?  Adrian G.
Evaluation of the Recommended Dose and Efficacy of Amrubicin as Second- and Third- Line Chemotherapy for Small Cell Lung Cancer  Satoshi Igawa, MD, PhD,
Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer  Masahiko Harada,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic Variation  Lars Soraas, MSc, Justin Stebbing,
Ellen Kim, MD, MPH, Siran Koroukian, PhD, Charles R. Thomas, MD 
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.
Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database 
Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer  Tateaki Naito, MD, PhD, Fumihiro Tanaka, MD, PhD, Akira Ono, MD,
Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q
Do Complex Mutations of the Epidermal Growth Factor Receptor Gene Reflect Intratumoral Heterogeneity?  Akito Hata, MD, Shiro Fujita, MD, PhD, Reiko Kaji,
Phase I and Pharmacokinetic Study of Combination Chemotherapy Using Irinotecan and Paclitaxel in Patients with Lung Cancer  Gyo Asai, MD, PhD, Nobuyuki.
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed  Emanuela Taioli, MD, PhD, Raja Flores, MD 
Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.
Disease Control as a Predictor of Survival with Gefitinib and Docetaxel in a Phase III Study (V-15-32) in Advanced Non-small Cell Lung Cancer Patients 
Mitotic Inhibitors Journal of Thoracic Oncology
A Translational View of the Molecular Pathogenesis of Lung Cancer
Mirror Mirror on the Wall, Who Is the Fairest of Them All
Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401) 
Multiple Primary Cancers or Multiple Metastases, That Is the Question
Relationship between Response and Survival in More Than 50,000 Patients with Advanced Non-small Cell Lung Cancer Treated with Systemic Chemotherapy in.
Peripheral Direct Adjacent Lobe Invasion Non-small Cell Lung Cancer Has a Similar Survival to That of Parietal Pleural Invasion T3 Disease  Hao-Xian Yang,
Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease?  Chenyang Dai, MD, Yijiu Ren, MD, Dong Xie, MD, PhD,
Conditional Survival of Malignant Thymoma Using National Population-Based Surveillance, Epidemiology, and End Results (SEER) Registry (1973–2011)  Ellen.
Journal of Thoracic Oncology
Phase I Study of Lenalidomide in Solid Tumors
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
The Port Site Recurrence after a Thoracoscopic and Video-Assisted Esophagectomy for Advanced Esophageal Cancer  Satoshi Yamamoto, PhD, Katsunobu Kawahara,
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?
In This Issue Journal of Thoracic Oncology
Genetic Changes in Squamous Cell Lung Cancer: A Review
European Lung Cancer Conference (ELCC) 2016 Organisation
S-1 Treatment for Chemorefractory Thymic Carcinoma
Pleural Metastases of Malignant Melanoma
IASLC 6th Latin American Conference on Lung Cancer
Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
Epidemiology of Thymoma and Associated Malignancies
Impact of Information on Quality of Life and Satisfaction of Non-small Cell Lung Cancer Patients: A Randomized Study of Standardized versus Individualized.
Thymic Small Cell Carcinoma Shows Marked Response to Amrubicin
Rogerio C. Lilenbaum, MD, John Cashy, PhD, Thomas A
Robert Comis, MD, The Passing of a “Lung Man”
Presentation transcript:

Multiplexed Molecular Profiling of Lung Cancer Using Pleural Effusion Hiroaki Akamatsu, MD, Yasuhiro Koh, MD, PhD, Hirotsugu Kenmotsu, MD, Tateaki Naito, MD, PhD, Masakuni Serizawa, PhD, Madoka Kimura, MD, Keita Mori, MSc, Hisao Imai, MD, PhD, Akira Ono, MD, PhD, Takehito Shukuya, MD, Tetsuhiko Taira, MD, PhD, Haruyasu Murakami, MD, PhD, Yasuhisa Ohde, MD, PhD, Masahiro Endo, MD, PhD, Takashi Nakajima, MD, PhD, Toshiaki Takahashi, MD, PhD, Nobuyuki Yamamoto, MD, PhD  Journal of Thoracic Oncology  Volume 9, Issue 7, Pages 1048-1052 (July 2014) DOI: 10.1097/JTO.0000000000000203 Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Flow chart of the patients analyzed in this study. Journal of Thoracic Oncology 2014 9, 1048-1052DOI: (10.1097/JTO.0000000000000203) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Proportion of samples with genetic abnormalities among whole population (N = 84), pathologically positive patients (N = 60), and pathologically negative patients (N = 17). In four patients, pathological diagnosis was not given. Journal of Thoracic Oncology 2014 9, 1048-1052DOI: (10.1097/JTO.0000000000000203) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Relative frequency of genetic abnormalities analyzed from 102 pleural effusion samples. Journal of Thoracic Oncology 2014 9, 1048-1052DOI: (10.1097/JTO.0000000000000203) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions